Leukemia Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Leukemia Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Leukemia Models Today - Breaking & Trending Today

SELLAS Life Sciences CDK9 Inhibitor GFH009 Selected for Pediatric Preclinical in Vivo Testing (PIVOT) Program in Pediatric Cancers by the National Cancer Institute

Published: December 6, 2022

GFH009 to be Evaluated Against Pediatric Solid Tumors and Leukemia Models at Eight Participating Research Institutions.

Source: pressreleasepoint.com

Related Topics:

United StatesAngelos StergiouNational Cancer InstituteJude Children Research HospitalMd Anderson Cancer CenterGenfleet Therapeutics Shanghai IncLife Sciences Group IncLeukemia Models At Eight Participating Research InstitutionsJackson LaboratoryMemorial Sloan Kettering Cancer CenterFunded Throughcooperative Agreement GrantsNational CancerEvaluated Against Pediatric Solid TumorsLeukemia ModelsEight Participating ResearchSciences GroupPediatric PreclinicalVivo TestingChief Executive OfficerJude ChildrenResearch HospitalCancer CenterTexas Health Science Center San AntonioSloan Kettering Cancer CenterCancer Inst Australia